Blogs
INSIGHTS & ARTICLES
DnXT Blog
Expert insights on regulatory operations, eCTD publishing, and digital transformation in life sciences.
Pharmaceutical EDMS Buyer’s Guide 2026: Beyond Regulatory Documents
A pharmaceutical EDMS in 2026 is judged on Part 11 e-signatures, audit trails, and how far it extends beyond regulatory — into quality, clinical, training, and inspection readiness.
eCTD Viewer Software: A 2026 Buyer’s Guide
Free eCTD viewers open a sequence. Enterprise review platforms answer the questions reviewers actually ask. Here's what separates them — including the FDA-forms problem nobody mentions in demos.
Health Authority Questions (HAQs): How to Prepare Before You Submit
Health authority questions are predictable — they cluster by discipline and CTD module. Teams that prepare for likely questions before submission cut review cycles and save hundreds of hours.
Health Authority Correspondence Tracking: The Missing System of Record in Regulatory Operations
Agency correspondence is legally consequential, deadline-driven, and — at most companies — scattered across inboxes. Here's what a real correspondence system of record looks like.
Regulatory Intelligence Software in 2026: Portfolio-Aware Scoring vs Generic News Feeds
Most regulatory intelligence software is a firehose. The useful question is not 'what changed?' but 'what changed that affects MY applications?' — and that requires portfolio-aware scoring.
Submission Planning Software: A 2026 Buyer’s Guide for Regulatory Teams
What submission planning software actually needs to do in 2026 — and how to evaluate the options, from Veeva RIM to generic project tools to purpose-built planners.
12 Questions to Ask Before Adopting AI in Regulatory Operations
A practical buyer's guide: 12 questions pharma and biotech companies should ask when evaluating AI-powered regulatory technology platforms.
Continuous Compliance Monitoring: How DnXT Watches Its Own Platform
An inside look at DnXT's Compliance Monitoring Dashboard — 6 compliance agents, 8 daily checks, and how continuous monitoring catches problems before auditors do.
The Case for an AI-Native Regulatory Platform (Not Another Bolt-On)
Why life sciences may need regulatory platforms designed for AI from the ground up — and the honest counter-arguments to that position.
What AI-Powered eCTD Validation Actually Looks Like in Practice
A practical look at eCTD validation: 23 compliance rules, multi-region support, and how AI helps with preparation while deterministic rules handle the actual checking.
Building a Compliance Workflow Engine That AI Agents Can Drive
A look inside DnXT's V5 workflow engine — 50+ endpoints, state machine architecture, and the preCheck pattern that lets AI agents look before they leap.
Why AI Agents Should Never Sign Documents — And How to Enforce That
Electronic signatures in regulated environments require human attribution. Here's why AI agents must be architecturally blocked from signing, not just told not to.
